Interferon-α and the liver monooxygenas system in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 140s Year: 2006
Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 724s Year: 2004
Effects of complex treatment with izofon of a pulmonary tuberculosis in children Source: Eur Respir J 2004; 24: Suppl. 48, 652s Year: 2004
Influence of thyroid function activity on the indexis of immunity in tuberculosis patients Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Activity of lysozyme in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
Morphology state of the liver of patients by lung tuberculosis, having pesticide action Source: Eur Respir J 2002; 20: Suppl. 38, 366s Year: 2002
Dynamics of carbohydrate metabolism in patients with destructive pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Effect of tobacco on the pulmonary tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012
Hepatic disorders in patients with pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 418s Year: 2005
Factors effecting the hepatic enzyme levels in tuberculosis patients with toxic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 73s Year: 2006
Influence of smoking in pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017
Evaluation of pulmonary function and functional capacity in patients with liver cirrhosis Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012
Tolerance and hepatotoxicity of different versions of polychemotherapy in patients with destructive pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001
Different antimycobacterial activity of macrophages in various lung tuberculosis legions of patients Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Relationship between tuberculosis and hepatic diseases Source: Eur Respir J 2005; 26: Suppl. 49, 423s Year: 2005
Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Intestinal parasiroses in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
The effect of antituberculosis chemotherapy on thyroid hormones in active pulmonary tuberculosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 306s Year: 2001
Characterization of the aetiological agent in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 12s Year: 2006